Thus, miR-378 increases both adipocyte hyperplasia and hypertrophy, whereas miR-142 inhibits adipogenic differentiation and autophagy in obesity, targeting Krueppel-like factor 9 [19]. Here, KLF9 is linked to obesity disorder.